Publications

Publications by Mouldy Sioud

210 publications found

Publications 2024

Sioud M, Juzeniene A, Sæbøe-Larssen S (2024)
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens
Vaccines (Basel), 12 (6)
DOI 10.3390/vaccines12060624, PubMed 38932353

Publications 2023

Sioud M (2023)
How the initial discovery of modified RNA enabled evasion of innate immune responses and facilitated the development of RNA therapeutics
Scand J Immunol, 98 (1), e13282
DOI 10.1111/sji.13282, PubMed 37132451
Sioud M, Olberg A (2023)
Antibody Surface Profiling Identifies Glycoforms in Multiple Myeloma as Targets for Immunotherapy: From Antibody Derivatives to Mimetic Peptides for Killing Tumor Cells
Cancers (Basel), 15 (7)
DOI 10.3390/cancers15071934, PubMed 37046595
Sioud M, Zhang Q (2023)
Precision Killing of M2 Macrophages with Phage-Displayed Peptide-Photosensitizer Conjugates
Cancers (Basel), 15 (7)
DOI 10.3390/cancers15072009, PubMed 37046671
Zhang Q, Sioud M (2023)
Tumor-Associated Macrophage Subsets: Shaping Polarization and Targeting
Int J Mol Sci, 24 (8)
DOI 10.3390/ijms24087493, PubMed 37108657

Publications 2022

Zhang Q, Olberg A, Sioud M (2022)
Structural Requirements for the Binding of a Peptide to Prohibitins on the Cell Surface of Monocytes/Macrophages
Int J Mol Sci, 23 (8)
DOI 10.3390/ijms23084282, PubMed 35457098

Publications 2021

Sioud M (2021)
RNA Interference: Story and Mechanisms
Methods Mol Biol, 2282, 1-15
DOI 10.1007/978-1-0716-1298-9_1, PubMed 33928566
Sioud M (2021)
Reducing the immunosuppressive tumor microenvironment enhances photoimmunotherapy efficacy
EBioMedicine, 67, 103351
DOI 10.1016/j.ebiom.2021.103351, PubMed 33965875
Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Cell Monolayer and Multicellular Tumor Spheroid Models
Cancers (Basel), 13 (13)
DOI 10.3390/cancers13133356, PubMed 34283089
Sioud M, Juzenas P, Zhang Q, Kleinauskas A, Peng Q (2021)
Correction: Sioud et al. Evaluation of In Vitro Phototoxicity of a Minibody-IR700 Conjugate Using Monolayer and Multicellular Tumor Spheroid Models. Cancers 2021, 13, 3356
Cancers (Basel), 13 (21)
DOI 10.3390/cancers13215513, PubMed 34771754

Publications 2020

Darvekar S, Juzenas P, Oksvold M, Kleinauskas A, Holien T, Christensen E, Stokke T, Sioud M, Peng Q (2020)
Selective Killing of Activated T Cells by 5-Aminolevulinic Acid Mediated Photodynamic Effect: Potential Improvement of Extracorporeal Photopheresis
Cancers (Basel), 12 (2)
DOI 10.3390/cancers12020377, PubMed 32041351
Iversen PO, Sioud M (2020)
Harnessing the Antiviral-Type Responses Induced by Immunostimulatory siRNAs for Cancer Immunotherapy
Methods Mol Biol, 2115, 281-287
DOI 10.1007/978-1-0716-0290-4_16, PubMed 32006407
Mobergslien A, Sioud M (2020)
Exploring 5'-Biotinylation of the Sense Strand to Improve siRNA Specificity and Potency
Methods Mol Biol, 2115, 163-170
DOI 10.1007/978-1-0716-0290-4_9, PubMed 32006400
Sioud M (2020)
RNA and CRISPR Interferences: Past, Present, and Future Perspectives
Methods Mol Biol, 2115, 1-22
DOI 10.1007/978-1-0716-0290-4_1, PubMed 32006392
Sioud M (2020)
Optimized siRNA Delivery into Primary Immune Cells Using Electroporation
Methods Mol Biol, 2115, 119-131
DOI 10.1007/978-1-0716-0290-4_7, PubMed 32006398
Sioud M (2020)
Unleashing the Therapeutic Potential of Dendritic and T Cell Therapies Using RNA Interference
Methods Mol Biol, 2115, 259-280
DOI 10.1007/978-1-0716-0290-4_15, PubMed 32006406
Sioud M (2020)
Microbial sensing by haematopoietic stem and progenitor cells: Vigilance against infections and immune education of myeloid cells
Scand J Immunol, 92 (5), e12957
DOI 10.1111/sji.12957, PubMed 32767789
Sæbøe-Larssen S, Sioud M (2020)
Improving Dendritic Cell Cancer Vaccine Potency Using RNA Interference
Methods Mol Biol, 2115, 249-258
DOI 10.1007/978-1-0716-0290-4_14, PubMed 32006405
Wälchli S, Sioud M (2020)
Next Generation of Adoptive T Cell Therapy Using CRISPR/Cas9 Technology: Universal or Boosted?
Methods Mol Biol, 2115, 407-417
DOI 10.1007/978-1-0716-0290-4_22, PubMed 32006413

Publications 2019

Sioud M (2019)
Releasing the Immune System Brakes Using siRNAs Enhances Cancer Immunotherapy
Cancers (Basel), 11 (2)
DOI 10.3390/cancers11020176, PubMed 30717461
Sioud M (2019)
Phage Display Libraries: From Binders to Targeted Drug Delivery and Human Therapeutics
Mol Biotechnol, 61 (4), 286-303
DOI 10.1007/s12033-019-00156-8, PubMed 30729435
Sioud M, Pettersen S, Ailte I, Fløisand Y (2019)
Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides
Cancers (Basel), 11 (8)
DOI 10.3390/cancers11081088, PubMed 31370273

Publications 2018

Peng W, de Bruijn HS, Farrell E, Sioud M, Mashayekhi V, Oliveira S, van Dam GM, Roodenburg JLN, Witjes MJH, Robinson DJ (2018)
Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines
Lasers Surg Med, 50 (5), 513-522
DOI 10.1002/lsm.22930, PubMed 29777587
Sioud M (2018)
T-cell cross-reactivity may explain the large variation in how cancer patients respond to checkpoint inhibitors
Scand J Immunol, 87 (3)
DOI 10.1111/sji.12643, PubMed 29381830
Sioud M, Westby P, Vasovic V, Fløisand Y, Peng Q (2018)
Development of a new high-affinity human antibody with antitumor activity against solid and blood malignancies
FASEB J, 32 (9), 5063-5077
DOI 10.1096/fj.201701544R, PubMed 29913558

Publications 2016

Mobergslien A, Peng Q, Vasovic V, Sioud M (2016)
Cancer cell-binding peptide fused Fc domain activates immune effector cells and blocks tumor growth
Oncotarget, 7 (46), 75940-75953
DOI 10.18632/oncotarget.12445, PubMed 27713158
Sioud M, Nyakas M, Sæbøe-Larssen S, Mobergslien A, Aamdal S, Kvalheim G (2016)
Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
Case Rep Med, 2016, 9639585
DOI 10.1155/2016/9639585, PubMed 27504122
Zins K, Schäfer R, Paulus P, Dobler S, Fakhari N, Sioud M, Aharinejad S, Abraham D (2016)
Frizzled2 signaling regulates growth of high-risk neuroblastomas by interfering with β-catenin-dependent and β-catenin-independent signaling pathways
Oncotarget, 7 (29), 46187-46202
DOI 10.18632/oncotarget.10070, PubMed 27323822

Publications 2015

Iversen PO, Sioud M (2015)
Engineering therapeutic cancer vaccines that activate antitumor immunity
Methods Mol Biol, 1218, 263-8
DOI 10.1007/978-1-4939-1538-5_15, PubMed 25319656
Mobergslien A, Sioud M (2015)
A facile method for interfering with off-target silencing mediated by the sense strand
Methods Mol Biol, 1218, 293-300
DOI 10.1007/978-1-4939-1538-5_18, PubMed 25319659
Mobergslien A, Vasovic V, Mathiesen G, Fredriksen L, Westby P, Eijsink VG, Peng Q, Sioud M (2015)
Recombinant Lactobacillus plantarum induces immune responses to cancer testis antigen NY-ESO-1 and maturation of dendritic cells
Hum Vaccin Immunother, 11 (11), 2664-73
DOI 10.1080/21645515.2015.1056952, PubMed 26185907
Sioud M (2015)
RNA interference: mechanisms, technical challenges, and therapeutic opportunities
Methods Mol Biol, 1218, 1-15
DOI 10.1007/978-1-4939-1538-5_1, PubMed 25319642
Sioud M (2015)
Cytoplasmic delivery of siRNAs to monocytes and dendritic cells via electroporation
Methods Mol Biol, 1218, 107-15
DOI 10.1007/978-1-4939-1538-5_6, PubMed 25319647
Sioud M (2015)
Strategies for siRNA navigation to desired cells
Methods Mol Biol, 1218, 201-16
DOI 10.1007/978-1-4939-1538-5_12, PubMed 25319653
Sioud M (2015)
Overcoming the challenges of siRNA activation of innate immunity: design better therapeutic siRNAs
Methods Mol Biol, 1218, 301-19
DOI 10.1007/978-1-4939-1538-5_19, PubMed 25319660
Sioud M (2015)
Modified 2'-ribose small RNAs function as Toll-like receptor-7/8 antagonists
Methods Mol Biol, 1218, 483-9
DOI 10.1007/978-1-4939-1538-5_28, PubMed 25319669
Sioud M, Mobergslien A, Sæbøe-Larssen S (2015)
Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses
Methods Mol Biol, 1218, 269-76
DOI 10.1007/978-1-4939-1538-5_16, PubMed 25319657
Sioud M, Westby P, Olsen JK, Mobergslien A (2015)
Generation of new peptide-Fc fusion proteins that mediate antibody-dependent cellular cytotoxicity against different types of cancer cells
Mol Ther Methods Clin Dev, 2, 15043
DOI 10.1038/mtm.2015.43, PubMed 26605373
Zins K, Sioud M, Aharinejad S, Lucas T, Abraham D (2015)
Modulating the tumor microenvironment with RNA interference as a cancer treatment strategy
Methods Mol Biol, 1218, 143-61
DOI 10.1007/978-1-4939-1538-5_9, PubMed 25319650

Publications 2014

Sioud M (2014)
Engineering better immunotherapies via RNA interference
Hum Vaccin Immunother, 10 (11), 3165-74
DOI 10.4161/hv.29754, PubMed 25483669

Publications 2013

Mobergslien A, Sioud M (2013)
Exosome-derived miRNAs and cellular miRNAs activate innate immunity
J Innate Immun, 6 (1), 105-10
DOI 10.1159/000351460, PubMed 23774807
Shahzidi S, Brech A, Sioud M, Li X, Suo Z, Nesland JM, Peng Q (2013)
Lamin A/C cleavage by caspase-6 activation is crucial for apoptotic induction by photodynamic therapy with hexaminolevulinate in human B-cell lymphoma cells
Cancer Lett, 339 (1), 25-32
DOI 10.1016/j.canlet.2013.07.026, PubMed 23916608
Sioud M, Saebøe-Larssen S, Hetland TE, Kaern J, Mobergslien A, Kvalheim G (2013)
Silencing of indoleamine 2,3-dioxygenase enhances dendritic cell immunogenicity and antitumour immunity in cancer patients
Int J Oncol, 43 (1), 280-8
DOI 10.3892/ijo.2013.1922, PubMed 23620105
Sioud M, Skorstad G, Mobergslien A, Sæbøe-Larssen S (2013)
A novel peptide carrier for efficient targeting of antigens and nucleic acids to dendritic cells
FASEB J, 27 (8), 3272-83
DOI 10.1096/fj.12-224758, PubMed 23671272
Zins K, Thomas A, Lucas T, Sioud M, Aharinejad S, Abraham D (2013)
Inhibition of stromal PlGF suppresses the growth of prostate cancer xenografts
Int J Mol Sci, 14 (9), 17958-71
DOI 10.3390/ijms140917958, PubMed 24005860

Publications 2012

Sioud M, Mobergslien A (2012)
Efficient siRNA targeted delivery into cancer cells by gastrin-releasing peptides
Bioconjug Chem, 23 (5), 1040-9
DOI 10.1021/bc300050j, PubMed 22443209
Sioud M, Mobergslien A (2012)
Selective killing of cancer cells by peptide-targeted delivery of an anti-microbial peptide
Biochem Pharmacol, 84 (9), 1123-32
DOI 10.1016/j.bcp.2012.08.002, PubMed 22922046

Publications 2011

Mobergslien A, Sioud M (2011)
Galectin-1 and -3 gene silencing in immature and mature dendritic cells enhances T cell activation and interferon-γ production
J Leukoc Biol, 91 (3), 461-7
DOI 10.1189/jlb.0711361, PubMed 22167721
Sioud M (2011)
Promises and challenges in developing RNAi as a research tool and therapy
Methods Mol Biol, 703, 173-87
DOI 10.1007/978-1-59745-248-9_12, PubMed 21125490
Sioud M (2011)
New insights into mesenchymal stromal cell-mediated T-cell suppression through galectins
Scand J Immunol, 73 (2), 79-84
DOI 10.1111/j.1365-3083.2010.02491.x, PubMed 21198747

Publications 2010

Abraham D, Zins K, Sioud M, Lucas T, Schäfer R, Stanley ER, Aharinejad S (2010)
Stromal cell-derived CSF-1 blockade prolongs xenograft survival of CSF-1-negative neuroblastoma
Int J Cancer, 126 (6), 1339-52
DOI 10.1002/ijc.24859, PubMed 19711348
Ben-Mahrez K, Sioud M (2010)
Presence of STRA-STRB linked streptomycin-resistance genes in clinical isolate of Escherichia coil 2418
Arch Inst Pasteur Tunis, 87 (1-2), 77-81
PubMed 21598829
Cekaite L, Clancy T, Sioud M (2010)
Increased miR-21 expression during human monocyte differentiation into DCs
Front Biosci (Elite Ed), 2 (3), 818-28
DOI 10.2741/e143, PubMed 20515755
Fløisand Y, Sioud M (2010)
Recent advances in hematopoietic stem cell transplantation and perspectives of RNAi applications
Methods Mol Biol, 629, 507-23
DOI 10.1007/978-1-60761-657-3_30, PubMed 20387168
Fredriksen L, Mathiesen G, Sioud M, Eijsink VG (2010)
Cell wall anchoring of the 37-kilodalton oncofetal antigen by Lactobacillus plantarum for mucosal cancer vaccine delivery
Appl Environ Microbiol, 76 (21), 7359-62
DOI 10.1128/AEM.01031-10, PubMed 20851975
Iversen PO, Sørensen DR, Sioud M (2010)
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia
Thromb Haemost, 104 (2), 350-4
DOI 10.1160/TH09-12-0816, PubMed 20539915
Mobergslien A, Sioud M (2010)
Optimized protocols for siRNA delivery into monocytes and dendritic cells
Methods Mol Biol, 629, 71-85
DOI 10.1007/978-1-60761-657-3_5, PubMed 20387143
Sioud M (2010)
Recent advances in small interfering RNA sensing by the immune system
N Biotechnol, 27 (3), 236-42
DOI 10.1016/j.nbt.2010.02.015, PubMed 20219711
Sioud M (2010)
Advances in RNA sensing by the immune system: separation of siRNA unwanted effects from RNA interference
Methods Mol Biol, 629, 33-52
DOI 10.1007/978-1-60761-657-3_3, PubMed 20387141
Sioud M (2010)
What are the key targeted delivery technologies of siRNA now?
Methods Mol Biol, 629, 93-107
DOI 10.1007/978-1-60761-657-3_7, PubMed 20387145
Sioud M (2010)
Development of TLR7/8 small RNA antagonists
Methods Mol Biol, 629, 387-94
DOI 10.1007/978-1-60761-657-3_25, PubMed 20387163
Sioud M (2010)
Modulation of dendritic cell maturation and function by siRNA-bearing 5'-triphosphate
Methods Mol Biol, 629, 395-404
DOI 10.1007/978-1-60761-657-3_26, PubMed 20387164
Sioud M (2010)
Overcoming self-tolerance to tumour cells
Methods Mol Biol, 629, 495-505
DOI 10.1007/978-1-60761-657-3_29, PubMed 20387167
Sioud M (2010)
RNA therapeutics: function, design, and delivery. Preface
Methods Mol Biol, 629, v-vii
DOI 10.1007/978-1-60761-657-3, PubMed 20394129
Sioud M, Cekaite L (2010)
Profiling of miRNA expression and prediction of target genes
Methods Mol Biol, 629, 257-71
DOI 10.1007/978-1-60761-657-3_16, PubMed 20387154
Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
Evidence for the involvement of galectin-3 in mesenchymal stem cell suppression of allogeneic T-cell proliferation
Scand J Immunol, 71 (4), 267-74
DOI 10.1111/j.1365-3083.2010.02378.x, PubMed 20384870
Sioud M, Mobergslien A, Boudabous A, Fløisand Y (2010)
Mesenchymal stem cell-mediated T cell suppression occurs through secreted galectins
Int J Oncol, 38 (2), 385-90
DOI 10.3892/ijo.2010.869, PubMed 21165555
Sørensen DR, Sioud M (2010)
Systemic delivery of synthetic siRNAs
Methods Mol Biol, 629, 87-91
DOI 10.1007/978-1-60761-657-3_6, PubMed 20387144

Publications 2009

Aharinejad S, Sioud M, Lucas T, Abraham D (2009)
Targeting stromal-cancer cell interactions with siRNAs
Methods Mol Biol, 487, 243-66
DOI 10.1007/978-1-60327-547-7_12, PubMed 19301651
Cekaite L, Hovig E, Sioud M (2009)
Monitoring B cell response to immunoselected phage-displayed peptides by microarrays
Methods Mol Biol, 524, 273-85
DOI 10.1007/978-1-59745-450-6_20, PubMed 19377952
Flatekval GF, Sioud M (2009)
Modulation of dendritic cell maturation and function with mono- and bifunctional small interfering RNAs targeting indoleamine 2,3-dioxygenase
Immunology, 128 (1 Suppl), e837-48
DOI 10.1111/j.1365-2567.2009.03093.x, PubMed 19740345
Hauge H, Fjelland KE, Sioud M, Aasheim HC (2009)
Evidence for the involvement of FAM110C protein in cell spreading and migration
Cell Signal, 21 (12), 1866-73
DOI 10.1016/j.cellsig.2009.08.001, PubMed 19698782
Iversen PO, Semaeva E, Sorensen DR, Wiig H, Sioud M (2009)
Dendritic Cells Loaded with Tumor Antigens and a Dual Immunostimulatory and Anti-Interleukin 10-Specific Small Interference RNA Prime T Lymphocytes against Leukemic Cells
Transl Oncol, 2 (4), 242-6
DOI 10.1593/tlo.09154, PubMed 19956385
Sioud M (2009)
Deciphering the code of innate immunity recognition of siRNAs
Methods Mol Biol, 487, 41-59
DOI 10.1007/978-1-60327-547-7_2, PubMed 19301641
Sioud M (2009)
Targeted delivery of antisense oligonucleotides and siRNAs into mammalian cells
Methods Mol Biol, 487, 61-82
DOI 10.1007/978-1-60327-547-7_3, PubMed 19301642
Sioud M (2009)
Does our current understanding of immune tolerance, autoimmunity, and immunosuppressive mechanisms facilitate the design of efficient cancer vaccines?
Scand J Immunol, 70 (6), 516-25
DOI 10.1111/j.1365-3083.2009.02326.x, PubMed 19906192
Sioud M, Boudabous A, Cekaite L (2009)
Transcriptional responses of Bacillus subtillis and thuringiensis to antibiotics and anti-tumour drugs
Int J Mol Med, 23 (1), 33-9
DOI 10.3892/ijmm_00000098, PubMed 19082504
Sioud M, Fløisand Y (2009)
NOD2/CARD15 on bone marrow CD34+ hematopoietic cells mediates induction of cytokines and cell differentiation
J Leukoc Biol, 85 (6), 939-46
DOI 10.1189/jlb.1008650, PubMed 19244164

Publications 2008

Abraham D, Zins K, Sioud M, Lucas T, Aharinejad S (2008)
Host CD147 blockade by small interfering RNAs suppresses growth of human colon cancer xenografts
Front Biosci, 13, 5571-9
DOI 10.2741/3100, PubMed 18508606
Chekenya M, Krakstad C, Svendsen A, Netland IA, Staalesen V, Tysnes BB, Selheim F, Wang J, Sakariassen PØ, Sandal T, Lønning PE, Flatmark T, Enger PØ, Bjerkvig R, Sioud M, Stallcup WB (2008)
The progenitor cell marker NG2/MPG promotes chemoresistance by activation of integrin-dependent PI3K/Akt signaling
Oncogene, 27 (39), 5182-94
DOI 10.1038/onc.2008.157, PubMed 18469852
Shadidi M, Sørensen D, Dybwad A, Furset G, Sioud M (2008)
Mucosal vaccination with phage-displayed tumour antigens identified through proteomics-based strategy inhibits the growth and metastasis of 4T1 breast adenocarcinoma
Int J Oncol, 32 (1), 241-7
PubMed 18097564
Sioud M (2008)
Does the understanding of immune activation by RNA predict the design of safe siRNAs?
Front Biosci, 13, 4379-92
DOI 10.2741/3011, PubMed 18508517
Sioud M, Cekaite L (2008)
Expression profiling of microRNAs in cancer cells: technical considerations
Methods Mol Biol, 439, 179-90
DOI 10.1007/978-1-59745-188-8_12, PubMed 18370103
Walchli S, Sioud M (2008)
Vector-based delivery of siRNAs: in vitro and in vivo challenges
Front Biosci, 13, 3488-93
DOI 10.2741/2943, PubMed 18508450

Publications 2007

Aharinejad S, Sioud M, Lucas T, Abraham D (2007)
Target validation using RNA interference in solid tumors
Methods Mol Biol, 361, 227-38
DOI 10.1385/1-59745-208-4:227, PubMed 17172715
Cekaite L, Hovig E, Sioud M (2007)
Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses
Methods Mol Biol, 360, 335-48
DOI 10.1385/1-59745-165-7:335, PubMed 17172738
Furset G, Fløisand Y, Sioud M (2007)
Impaired expression of indoleamine 2, 3-dioxygenase in monocyte-derived dendritic cells in response to Toll-like receptor-7/8 ligands
Immunology, 123 (2), 263-71
DOI 10.1111/j.1365-2567.2007.02695.x, PubMed 17725606
Røsok Ø, Sioud M (2007)
Discovery of differentially expressed genes: technical considerations
Methods Mol Biol, 360, 115-29
DOI 10.1385/1-59745-165-7:115, PubMed 17172727
Sioud M (2007)
Main approaches to target discovery and validation
Methods Mol Biol, 360, 1-12
DOI 10.1385/1-59745-165-7:1, PubMed 17172722
Sioud M (2007)
An overview of the immune system and technical advances in tumor antigen discovery and validation
Methods Mol Biol, 360, 277-318
DOI 10.1385/1-59745-165-7:277, PubMed 17172735
Sioud M (2007)
RNA interference and innate immunity
Adv Drug Deliv Rev, 59 (2-3), 153-63
DOI 10.1016/j.addr.2007.03.006, PubMed 17459518
Sioud M, Fløisand Y (2007)
TLR agonists induce the differentiation of human bone marrow CD34+ progenitors into CD11c+ CD80/86+ DC capable of inducing a Th1-type response
Eur J Immunol, 37 (10), 2834-46
DOI 10.1002/eji.200737112, PubMed 17853407
Sioud M, Furset G, Cekaite L (2007)
Suppression of immunostimulatory siRNA-driven innate immune activation by 2'-modified RNAs
Biochem Biophys Res Commun, 361 (1), 122-6
DOI 10.1016/j.bbrc.2007.06.177, PubMed 17658482
Sioud M, Leirdal M (2007)
Druggable signaling proteins
Methods Mol Biol, 361, 1-24
DOI 10.1385/1-59745-208-4:1, PubMed 17172705
Sioud M, Melien O (2007)
Treatment options and individualized medicine
Methods Mol Biol, 361, 327-40
DOI 10.1385/1-59745-208-4:327, PubMed 17172721
Zins K, Abraham D, Sioud M, Aharinejad S (2007)
Colon cancer cell-derived tumor necrosis factor-alpha mediates the tumor growth-promoting response in macrophages by up-regulating the colony-stimulating factor-1 pathway
Cancer Res, 67 (3), 1038-45
DOI 10.1158/0008-5472.CAN-06-2295, PubMed 17283136

Publications 2006

Angell-Petersen E, Spetalen S, Madsen SJ, Sun CH, Peng Q, Carper SW, Sioud M, Hirschberg H (2006)
Influence of light fluence rate on the effects of photodynamic therapy in an orthotopic rat glioma model
J Neurosurg, 104 (1), 109-17
DOI 10.3171/jns.2006.104.1.109, PubMed 16509154
Cekaite L, Furset G, Hovig E, Sioud M (2006)
Gene expression analysis in blood cells in response to unmodified and 2'-modified siRNAs reveals TLR-dependent and independent effects
J Mol Biol, 365 (1), 90-108
DOI 10.1016/j.jmb.2006.09.034, PubMed 17054988
Furset G, Sioud M (2006)
Design of bifunctional siRNAs: combining immunostimulation and gene-silencing in one single siRNA molecule
Biochem Biophys Res Commun, 352 (3), 642-9
DOI 10.1016/j.bbrc.2006.11.059, PubMed 17150189
Huynh T, Wälchli S, Sioud M (2006)
Transcriptional targeting of small interfering RNAs into cancer cells
Biochem Biophys Res Commun, 350 (4), 854-9
DOI 10.1016/j.bbrc.2006.09.127, PubMed 17034763
Sioud M (2006)
Innate sensing of self and non-self RNAs by Toll-like receptors
Trends Mol Med, 12 (4), 167-76
DOI 10.1016/j.molmed.2006.02.004, PubMed 16530484
Sioud M (2006)
Ribozymes and siRnas: from structure to preclinical applications
Handb Exp Pharmacol (173), 223-42
DOI 10.1007/3-540-27262-3_11, PubMed 16594618
Sioud M (2006)
Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: a central role for 2'-hydroxyl uridines in immune responses
Eur J Immunol, 36 (5), 1222-30
DOI 10.1002/eji.200535708, PubMed 16609928
Sioud M (2006)
RNA interference below the immune radar
Nat Biotechnol, 24 (5), 521-2
DOI 10.1038/nbt0506-521, PubMed 16680132
Sioud M (2006)
RNAi therapy: antibodies guide the way
Gene Ther, 13 (3), 194-5
DOI 10.1038/sj.gt.3302634, PubMed 17243203
Sioud M, Fløisand Y, Forfang L, Lund-Johansen F (2006)
Signaling through toll-like receptor 7/8 induces the differentiation of human bone marrow CD34+ progenitor cells along the myeloid lineage
J Mol Biol, 364 (5), 945-54
DOI 10.1016/j.jmb.2006.09.054, PubMed 17049554
Sioud M, Furset G (2006)
Molecular basis for the immunostimulatory potency of small interfering RNAs
J Biomed Biotechnol, 2006 (4), 23429
DOI 10.1155/JBB/2006/23429, PubMed 17057361
Sioud M, Haoudi A (2006)
RNA interference
J Biomed Biotechnol, 2006 (4), 89018
DOI 10.1155/JBB/2006/89018, PubMed 17057373

Publications 2005

Patzke S, Hauge H, Sioud M, Finne EF, Sivertsen EA, Delabie J, Stokke T, Aasheim HC (2005)
Identification of a novel centrosome/microtubule-associated coiled-coil protein involved in cell-cycle progression and spindle organization
Oncogene, 24 (7), 1159-73
DOI 10.1038/sj.onc.1208267, PubMed 15580290
Røsok O, Sioud M (2005)
Systematic search for natural antisense transcripts in eukaryotes (review)
Int J Mol Med, 15 (2), 197-203
PubMed 15647831
Sioud M (2005)
Induction of inflammatory cytokines and interferon responses by double-stranded and single-stranded siRNAs is sequence-dependent and requires endosomal localization
J Mol Biol, 348 (5), 1079-90
DOI 10.1016/j.jmb.2005.03.013, PubMed 15854645
Sioud M (2005)
siRNA delivery in vivo
Methods Mol Biol, 309, 237-49
DOI 10.1385/1-59259-935-4:237, PubMed 15990404
Sioud M (2005)
On the delivery of small interfering RNAs into mammalian cells
Expert Opin Drug Deliv, 2 (4), 639-51
DOI 10.1517/17425247.2.4.639, PubMed 16296791
Sioud M, Iversen PO (2005)
Ribozymes, DNAzymes and small interfering RNAs as therapeutics
Curr Drug Targets, 6 (6), 647-53
DOI 10.2174/1389450054863653, PubMed 16178798
Sioud M, Røsok Ø (2005)
High-throughput analysis of microRNA gene expression using sensitive probes
Methods Mol Biol, 309, 311-20
DOI 10.1385/1-59259-935-4:311, PubMed 15990410
Sioud M, Wälchli S (2005)
Strategies for the design of random siRNA libraries and the selection of anti-GFP siRNAs
Methods Mol Biol, 309, 83-91
DOI 10.1385/1-59259-935-4:083, PubMed 15990399

Publications 2004

Aharinejad S, Paulus P, Sioud M, Hofmann M, Zins K, Schäfer R, Stanley ER, Abraham D (2004)
Colony-stimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice
Cancer Res, 64 (15), 5378-84
DOI 10.1158/0008-5472.CAN-04-0961, PubMed 15289345
Cekaite L, Haug O, Myklebost O, Aldrin M, Østenstad B, Holden M, Frigessi A, Hovig E, Sioud M (2004)
Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method
Proteomics, 4 (9), 2572-82
DOI 10.1002/pmic.200300768, PubMed 15352232
Hirschberg H, Madsen S, Angell-Petersen E, Peng Q, Sioud M, Sun CH, Sorensen DR (2004)
Repetitive 5-aminolevulinic acid mediated photodynamic therapy of rat glioma
P SOC PHOTO-OPT INS, 5312, 405-414
DOI 10.1117/12.527395
Iversen PO, Sioud M (2004)
Inhibition of gene expression by nucleic acid enzymes in rodent models of human disease
Methods Mol Biol, 252, 451-6
DOI 10.1385/1-59259-746-7:451, PubMed 15017070
Leirdal M, Shadidy M, Røsok Ø, Sioud M (2004)
Identification of genes differentially expressed in breast cancer cell line SKBR3: potential identification of new prognostic biomarkers
Int J Mol Med, 14 (2), 217-22
PubMed 15254768
Leirdal M, Sioud M (2004)
Gene-array analysis of glioma cells after treatment with an anti-PKCalpha siRNA: a general protocol
Methods Mol Biol, 252, 493-500
DOI 10.1385/1-59259-746-7:493, PubMed 15017074
Røsok O, Sioud M (2004)
An experimental approach for systematic identification of antisense transcripts
Discov Med, 4 (20), 58-60
PubMed 20705023
Shadidi M, Sioud M (2004)
Selection of peptides for specific delivery of oligonucleotides into cancer cells
Methods Mol Biol, 252, 569-80
DOI 10.1385/1-59259-746-7:569, PubMed 15017081
Sioud M (2004)
Therapeutic siRNAs
Trends Pharmacol Sci, 25 (1), 22-8
DOI 10.1016/j.tips.2003.11.006, PubMed 14723975
Sioud M (2004)
Ribozyme- and siRNA-mediated mRNA degradation: a general introduction
Methods Mol Biol, 252, 1-8
DOI 10.1385/1-59259-746-7:001, PubMed 15017038
Sioud M (2004)
Therapeutic potential of small interfering RNAs
Drug Future, 29 (7), 741-750
DOI 10.1358/dof.2004.029.07.854171
Sioud M, Leirdal M (2004)
Potential design rules and enzymatic synthesis of siRNAs
Methods Mol Biol, 252, 457-69
DOI 10.1385/1-59259-746-7:457, PubMed 15017071
Sioud M, Røsok O (2004)
Profiling microRNA expression using sensitive cDNA probes and filter arrays
Biotechniques, 37 (4), 574-6, 578-80
DOI 10.2144/04374ST01, PubMed 15517969
Sioud M, Sørensen DR (2004)
Systemic delivery of synthetic siRNAs
Methods Mol Biol, 252, 515-22
DOI 10.1385/1-59259-746-7:515, PubMed 15017077

Publications 2003

Dybwad A, Lambin P, Sioud M, Zouali M (2003)
Probing the specificity of human myeloma proteins with a random peptide phage library
Scand J Immunol, 57 (6), 583-90
DOI 10.1046/j.1365-3083.2003.01254.x, PubMed 12791097
Røsok Ø, Sioud M (2003)
Systematic identification of sense-antisense transcripts in mammalian cells
Nat Biotechnol, 22 (1), 104-8
DOI 10.1038/nbt925, PubMed 14704709
Shadidi M, Sioud M (2003)
Selective targeting of cancer cells using synthetic peptides
Drug Resist Updat, 6 (6), 363-71
DOI 10.1016/j.drup.2003.11.002, PubMed 14744500
Sioud M, Sørensen D (2003)
Generation of an effective anti-tumor immunity after immunization with xenogeneic antigens
Eur J Immunol, 33 (1), 38-45
DOI 10.1002/immu.200390005, PubMed 12594830
Sioud M, Sørensen DR (2003)
Cationic liposome-mediated delivery of siRNAs in adult mice
Biochem Biophys Res Commun, 312 (4), 1220-5
DOI 10.1016/j.bbrc.2003.11.057, PubMed 14652004
Sørensen DR, Leirdal M, Sioud M (2003)
Gene silencing by systemic delivery of synthetic siRNAs in adult mice
J Mol Biol, 327 (4), 761-6
DOI 10.1016/s0022-2836(03)00181-5, PubMed 12654261

Publications 2002

Iversen PO, Emanuel PD, Sioud M (2002)
Targeting Raf-1 gene expression by a DNA enzyme inhibits juvenile myelomonocytic leukemia cell growth
Blood, 99 (11), 4147-53
DOI 10.1182/blood.v99.11.4147, PubMed 12010819
Leirdal M, Sioud M (2002)
[Tyrosine kinase receptor-ras-ERK signal transduction pathway as therapeutic tarfet in cancer]
Tidsskr Nor Laegeforen, 122 (2), 178-82
PubMed 11873574
Leirdal M, Sioud M (2002)
Gene silencing in mammalian cells by preformed small RNA duplexes
Biochem Biophys Res Commun, 295 (3), 744-8
DOI 10.1016/s0006-291x(02)00736-2, PubMed 12099702
Shadidi M, Sioud M (2002)
Identification of novel carrier peptides for the specific delivery of therapeutics into cancer cells
FASEB J, 17 (2), 256-8
DOI 10.1096/fj.02-0280fje, PubMed 12490548
Sioud M (2002)
How does autoimmunity cause tumor regression? A potential mechanism involving cross-reaction through epitope mimicry
Mol Med, 8 (3), 115-9
DOI 10.1007/BF03402004, PubMed 12142543
Sorensen DR, Leirdal M, Iversen PO, Sioud M (2002)
Combination of endostatin and a protein kinase Calpha DNA enzyme improves the survival of rats with malignant glioma
Neoplasia, 4 (6), 474-9
DOI 10.1038/sj.neo.7900271, PubMed 12407440

Publications 2001

Hansen MH, Ostenstad B, Sioud M (2001)
Antigen-specific IgG antibodies in stage IV long-time survival breast cancer patients
Mol Med, 7 (4), 230-9
DOI 10.1007/BF03401842, PubMed 11471567
Hansen MH, Ostenstad B, Sioud M (2001)
Identification of immunogenic antigens using a phage-displayed cDNA library from an invasive ductal breast carcinoma tumour
Int J Oncol, 19 (6), 1303-9
DOI 10.3892/ijo.19.6.1303, PubMed 11713604
Iversen PO, Nicolaysen G, Sioud M (2001)
DNA enzyme targeting TNF-alpha mRNA improves hemodynamic performance in rats with postinfarction heart failure
Am J Physiol Heart Circ Physiol, 281 (5), H2211-7
DOI 10.1152/ajpheart.2001.281.5.H2211, PubMed 11668085
Melien O, Christoffersen T, Sioud M (2001)
Evidence for the involvement of Gi2 in activation of extracellular signal-regulated kinases in hepatocytes
BMC Cell Biol, 2, 13
DOI 10.1186/1471-2121-2-13, PubMed 11495629
Shadidi M, Sioud M (2001)
An anti-leukemic single chain Fv antibody selected from a synthetic human phage antibody library
Biochem Biophys Res Commun, 280 (2), 548-52
DOI 10.1006/bbrc.2000.4158, PubMed 11162553
Sioud M (2001)
Nucleic acid enzymes as a novel generation of anti-gene agents
Curr Mol Med, 1 (5), 575-88
DOI 10.2174/1566524013363366, PubMed 11899232
Sioud M, Hansen MH (2001)
Profiling the immune response in patients with breast cancer by phage-displayed cDNA libraries
Eur J Immunol, 31 (3), 716-25
DOI 10.1002/1521-4141(200103)31:3<716::aid-immu716>3.0.co;2-9, PubMed 11241275

Publications 2000

Hansen MH, Dybwad A, Førre O, Sioud M (2000)
Probing antinuclear antibody specificities by peptide phage display libraries
Clin Exp Rheumatol, 18 (4), 465-72
PubMed 10949721
Josefsen D, Myklebust JH, Lømo J, Sioud M, Blomhoff HK, Smeland EB (2000)
Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells
Stem Cells, 18 (4), 261-72
DOI 10.1634/stemcells.18-4-261, PubMed 10924092
Leirdal M, Sioud M (2000)
Protein kinase Calpha isoform regulates the activation of the MAP kinase ERK1/2 in human glioma cells: involvement in cell survival and gene expression
Mol Cell Biol Res Commun, 4 (2), 106-10
DOI 10.1006/mcbr.2000.0259, PubMed 11170840
Myklebust JH, Smeland EB, Josefsen D, Sioud M (2000)
Protein kinase C-alpha isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow
Blood, 95 (2), 510-8
DOI 10.1182/blood.V95.2.510, PubMed 10627456
Sioud M, Hansen M, Dybwad A (2000)
Profiling the immune responses in patient sera with peptide and cDNA display libraries
Int J Mol Med, 6 (2), 123-8
DOI 10.3892/ijmm.6.2.123, PubMed 10891554
Sioud M, Leirdal M (2000)
Design of nuclease resistant protein kinase calpha DNA enzymes with potential therapeutic application
J Mol Biol, 296 (3), 937-47
DOI 10.1006/jmbi.2000.3491, PubMed 10677293
Sioud M, Leirdal M (2000)
Therapeutic RNA and DNA enzymes
Biochem Pharmacol, 60 (8), 1023-6
DOI 10.1016/s0006-2952(00)00395-6, PubMed 11007937

Publications 1999

Leirdal M, Sioud M (1999)
Ribozyme inhibition of the protein kinase C alpha triggers apoptosis in glioma cells
Br J Cancer, 80 (10), 1558-64
DOI 10.1038/sj.bjc.6690560, PubMed 10408397
Sioud M (1999)
Application of preformed hammerhead ribozymes in the gene therapy of cancer (review)
Int J Mol Med, 3 (4), 381-4
DOI 10.3892/ijmm.3.4.381, PubMed 10085409
Sioud M, Leirdal M (1999)
Substitution of the 2'-hydroxyl group at position 2.1 by an amino group interferes with Mg(2+) binding and efficient cleavage by hammerhead ribozyme
Biochem Biophys Res Commun, 262 (2), 461-6
DOI 10.1006/bbrc.1999.1236, PubMed 10462497

Publications 1998

Iversen PO, Sioud M (1998)
Modulation of granulocyte-macrophage colony-stimulating factor gene expression by a tumor necrosis factor specific ribozyme in juvenile myelomonocytic leukemic cells
Blood, 92 (11), 4263-8
DOI 10.1182/blood.V92.11.4263.422k46_4263_4268, PubMed 9834232
Leirdal M, Sioud M (1998)
High cleavage activity and stability of hammerhead ribozymes with a uniform 2'-amino pyrimidine modification
Biochem Biophys Res Commun, 250 (1), 171-4
DOI 10.1006/bbrc.1998.9286, PubMed 9735351
Sioud M, Mellbye O, Førre O (1998)
Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA
Clin Exp Rheumatol, 16 (2), 125-34
PubMed 9536387
Sioud M, Sørensen DR (1998)
A nuclease-resistant protein kinase C alpha ribozyme blocks glioma cell growth
Nat Biotechnol, 16 (6), 556-61
DOI 10.1038/nbt0698-556, PubMed 9624687

Publications 1997

Dybwad A, Fłrre O, Sioud M (1997)
Probing for cerebrospinal fluid antibody specificities by a panel of random peptide libraries
Autoimmunity, 25 (2), 85-9
DOI 10.3109/08916939708996274, PubMed 9189009
Sioud M (1997)
Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates
Nucleic Acids Res, 25 (2), 333-8
DOI 10.1093/nar/25.2.333, PubMed 9016562
Sioud M, Opstad A, Hendry P, Lockett TJ, Jennings PA, McCall MJ (1997)
A minimised hammerhead ribozyme with activity against interleukin-2 in human cells
Biochem Biophys Res Commun, 231 (2), 397-402
DOI 10.1006/bbrc.1997.6099, PubMed 9070287

Publications 1996

Dybwad A, Førre O, Sioud M (1996)
Increased serum and synovial fluid antibodies to immunoselected peptides in patients with rheumatoid arthritis
Ann Rheum Dis, 55 (7), 437-41
DOI 10.1136/ard.55.7.437, PubMed 8774161
Fakhfakh F, Ayadi H, Bahloul Z, Jarraya A, Sioud M, Zouali M (1996)
Antibody epitopes probed by immunoselected phage-display library peptides in members of a family with various rheumatic manifestations
Clin Exp Rheumatol, 14 (6), 607-11
PubMed 8978954
Sioud M (1996)
Ribozyme modulation of lipopolysaccharide-induced tumor necrosis factor-alpha production by peritoneal cells in vitro and in vivo
Eur J Immunol, 26 (5), 1026-31
DOI 10.1002/eji.1830260511, PubMed 8647163
Sioud M, Førre O, Dybwad A (1996)
Selection of ligands for polyclonal antibodies from random peptide libraries: potential identification of (auto)antigens that may trigger B and T cell responses in autoimmune diseases
Clin Immunol Immunopathol, 79 (2), 105-14
DOI 10.1006/clin.1996.0057, PubMed 8620616
Sioud M, Jespersen L (1996)
Enhancement of hammerhead ribozyme catalysis by glyceraldehyde-3-phosphate dehydrogenase
J Mol Biol, 257 (4), 775-89
DOI 10.1006/jmbi.1996.0201, PubMed 8636981
Tougourti MN, Sioud M, Hassen Z, Bouhali R, Hamza M (1996)
[Psychiatric disorders and endocrine diseases. Apropos of a 8 cases]
Tunis Med, 74 (12), 549-52
PubMed 9506057

Publications 1995

Dybwad A, Bogen B, Natvig JB, Førre O, Sioud M (1995)
Peptide phage libraries can be an efficient tool for identifying antibody ligands for polyclonal antisera
Clin Exp Immunol, 102 (2), 438-42
DOI 10.1111/j.1365-2249.1995.tb03802.x, PubMed 7586703
Dybwad A, Førre O, Natvig JB, Sioud M (1995)
Structural characterization of peptides that bind synovial fluid antibodies from RA patients: a novel strategy for identification of disease-related epitopes using a random peptide library
Clin Immunol Immunopathol, 75 (1), 45-50
DOI 10.1006/clin.1995.1051, PubMed 7533685
Kjeldsen-Kragh J, Mellbye OJ, Haugen M, Mollnes TE, Hammer HB, Sioud M, Førre O (1995)
Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet
Scand J Rheumatol, 24 (2), 85-93
DOI 10.3109/03009749509099290, PubMed 7747149
Kjeldsen-Kragh J, Rashid T, Dybwad A, Sioud M, Haugen M, Førre O, Ebringer A (1995)
Decrease in anti-Proteus mirabilis but not anti-Escherichia coli antibody levels in rheumatoid arthritis patients treated with fasting and a one year vegetarian diet
Ann Rheum Dis, 54 (3), 221-4
DOI 10.1136/ard.54.3.221, PubMed 7748020
Ostenstad B, Dybwad A, Lea T, Førre O, Vinje O, Sioud M (1995)
Evidence for monoclonal expansion of synovial T cells bearing V alpha 2.1/V beta 5.5 gene segments and recognizing a synthetic peptide that shares homology with a number of putative autoantigens
Immunology, 86 (2), 168-75
PubMed 7490114
Ostenstad B, Sioud M, Schlichting E, Lea T, Harboe M (1995)
Freshly isolated tumour-infiltrating T-lymphocytes have a high cytotoxic potential, as measured by their ability to induce apoptosis in the target cell
Scand J Immunol, 41 (1), 42-8
DOI 10.1111/j.1365-3083.1995.tb03531.x, PubMed 7824887
Tougourti MN, Sioud M, Hamza M (1995)
[Cerebrovascular accidents in Horton's disease. Apropos of a case]
Tunis Med, 73 (5), 195-9
PubMed 9507283
Tougourti MN, Sioud M, Kheder L, Hamza M, Miled M (1995)
[Antiphospholipid syndrome]
Tunis Med, 73 (2), 95-103
PubMed 9506150

Publications 1994

NATVIG JB, WILSON KB, QUAYLE A, SULEYMAN S, KJELDSENKRAGH J, FORRE O, SIOUD M, CAPRA JD (1994)
T-CELL RECEPTOR VARIABLE GENE REPERTOIRE IN RHEUMATOID SYNOVIAL T-CELLS RESPONDING TO BCG
NATO ADV SCI INST SE, 80, 191-196
Ostenstad B, Sioud M, Lea T, Schlichting E, Harboe M (1994)
Limited heterogeneity in the T-cell receptor V-gene usage in lymphocytes infiltrating human colorectal tumours
Br J Cancer, 69 (6), 1078-82
DOI 10.1038/bjc.1994.211, PubMed 8198973
Sioud M (1994)
Interaction between tumour necrosis factor alpha ribozyme and cellular proteins. Involvement in ribozyme stability and activity
J Mol Biol, 242 (5), 619-29
DOI 10.1006/jmbi.1994.1612, PubMed 7932719
Sioud M, Dybwad A, Jespersen L, Suleyman S, Natvig JB, Førre O (1994)
Characterization of naturally occurring autoantibodies against tumour necrosis factor-alpha (TNF-alpha): in vitro function and precise epitope mapping by phage epitope library
Clin Exp Immunol, 98 (3), 520-5
DOI 10.1111/j.1365-2249.1994.tb05522.x, PubMed 7994916
Sioud M, Opstad A, Zhao JQ, Levitz R, Benham C, Drlica K (1994)
In vivo decay kinetic parameters of hammerhead ribozymes
Nucleic Acids Res, 22 (25), 5571-5
DOI 10.1093/nar/22.25.5571, PubMed 7838709
Suleyman S, Thompson KM, Førre O, Sioud M, Randen I, Mageed RA, Natvig JB (1994)
Three new cross-reacting idiotopes as markers for the products of two distinct human VH3 genes expressed in the early repertoire
Scand J Immunol, 40 (6), 681-90
DOI 10.1111/j.1365-3083.1994.tb03524.x, PubMed 7527936
Tougourti MN, Sioud M, Khedher I, Houman H, Hamza M, Miled M (1994)
[Iatrogenic accidents in the hospital environment]
Tunis Med, 72 (11), 625-30
PubMed 7762090

Publications 1993

Dybwad A, Førre O, Kjeldsen-Kragh J, Natvig JB, Sioud M (1993)
Identification of new B cell epitopes in the sera of rheumatoid arthritis patients using a random nanopeptide phage library
Eur J Immunol, 23 (12), 3189-93
DOI 10.1002/eji.1830231222, PubMed 7504991
Førre O, Sioud M (1993)
T cell receptor variable region gene usage in juvenile chronic arthritis
Clin Exp Rheumatol, 11 Suppl 9, S43-6
PubMed 8354007
Kjeldsen-Kragh J, Quayle AJ, Skålhegg BS, Sioud M, Førre O (1993)
Selective activation of resting human gamma delta T lymphocytes by interleukin-2
Eur J Immunol, 23 (9), 2092-9
DOI 10.1002/eji.1830230908, PubMed 8370391
Suleyman S, Hosono O, Sioud M, Randen I, Thompson KM, Førre O, Natvig JB (1993)
Differentiation of human lambda I variable regions with a monoclonal antibody to a defined, germ-line-encoded idiotope correlates with V lambda Ia chemical structure
J Immunol, 150 (12), 5466-75
PubMed 8515071

Publications 1992

Quayle AJ, Wilson KB, Li SG, Kjeldsen-Kragh J, Oftung F, Shinnick T, Sioud M, Førre O, Capra JD, Natvig JB (1992)
Peptide recognition, T cell receptor usage and HLA restriction elements of human heat-shock protein (hsp) 60 and mycobacterial 65-kDa hsp-reactive T cell clones from rheumatoid synovial fluid
Eur J Immunol, 22 (5), 1315-22
DOI 10.1002/eji.1830220529, PubMed 1577070
Sioud M, Kjeldsen-Kragh J, Suleyman S, Vinje O, Natvig JB, Førre O (1992)
Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells
Eur J Immunol, 22 (9), 2413-8
DOI 10.1002/eji.1830220934, PubMed 1387614
Sioud M, Natvig JB, Førre O (1992)
Preformed ribozyme destroys tumour necrosis factor mRNA in human cells
J Mol Biol, 223 (4), 831-5
DOI 10.1016/0022-2836(92)90244-e, PubMed 1538398
Waalen K, Sioud M, Natvig JB, Førre O (1992)
Spontaneous in vivo gene transcription of interleukin-2, interleukin-3, interleukin-4, interleukin-6, interferon-gamma, interleukin-2 receptor (CD25) and proto-oncogene c-myc by rheumatoid synovial T lymphocytes
Scand J Immunol, 36 (6), 865-73
DOI 10.1111/j.1365-3083.1992.tb03148.x, PubMed 1462123

Publications 1991

Sioud M, Drlica K (1991)
Prevention of human immunodeficiency virus type 1 integrase expression in Escherichia coli by a ribozyme
Proc Natl Acad Sci U S A, 88 (16), 7303-7
DOI 10.1073/pnas.88.16.7303, PubMed 1871136
Sioud M, Førre O, Natvig JB (1991)
T cell receptor delta diversity of freshly isolated T lymphocytes in rheumatoid synovitis
Eur J Immunol, 21 (1), 239-41
DOI 10.1002/eji.1830210137, PubMed 1825059
Sioud M, Kjeldsen-Kragh J, Quayle AJ, Wiker HG, Sørskaar D, Natvig JB, Førre O (1991)
Immune responses to 18.6 and 30-kDa mycobacterial antigens in rheumatoid patients, and V beta usage by specific synovial T-cell lines and fresh T cells
Scand J Immunol, 34 (6), 803-12
DOI 10.1111/j.1365-3083.1991.tb01605.x, PubMed 1836278

Publications 1990

Pascual V, Randen I, Thompson K, Sioud M, Forre O, Natvig J, Capra JD (1990)
The complete nucleotide sequences of the heavy chain variable regions of six monospecific rheumatoid factors derived from Epstein-Barr virus-transformed B cells isolated from the synovial tissue of patients with rheumatoid arthritis. Further evidence that some autoantibodies are unmutated copies of germ line genes
J Clin Invest, 86 (4), 1320-8
DOI 10.1172/JCI114841, PubMed 2170450
Sioud M, Kjeldsen-Kragh J, Quayle A, Kalvenes C, Waalen K, Førre O, Natvig JB (1990)
The V delta gene usage by freshly isolated T lymphocytes from synovial fluids in rheumatoid synovitis: a preliminary report
Scand J Immunol, 31 (4), 415-21
DOI 10.1111/j.1365-3083.1990.tb02787.x, PubMed 1692153

Publications 1989

Forterre P, Elie C, Sioud M, Hamal A (1989)
Studies on DNA polymerases and topoisomerases in archaebacteria
Can J Microbiol, 35 (1), 228-33
DOI 10.1139/m89-035, PubMed 2541877
Quayle A, Kjeldsen-Kragh J, Førre O, Waalen K, Sioud M, Kalvenes C, Natvig JB (1989)
Immunoregulatory T cell subsets and T cell activation in rheumatoid arthritis. A need for analysis on the clonal and molecular level
Springer Semin Immunopathol, 11 (3), 273-87
DOI 10.1007/BF00197307, PubMed 2575800
Sioud M, Forterre P (1989)
Ciprofloxacin and etoposide (VP16) produce a similar pattern of DNA cleavage in a plasmid of an archaebacterium
Biochemistry, 28 (9), 3638-41
DOI 10.1021/bi00435a002, PubMed 2751986

Publications 1988

Sioud M, Baldacci G, de Recondo AM, Forterre P (1988)
Inhibitors of DNA topoisomerase II induce topological changes in an archaebacterial plasmid in vivo
Biochem Pharmacol, 37 (9), 1879-80
DOI 10.1016/0006-2952(88)90492-3, PubMed 2837247
Sioud M, Baldacci G, de Recondo AM, Forterre P (1988)
Novobiocin induces positive supercoiling of small plasmids from halophilic archaebacteria in vivo
Nucleic Acids Res, 16 (4), 1379-91
DOI 10.1093/nar/16.4.1379, PubMed 3347494
Sioud M, Baldacci G, Forterre P, de Recondo AM (1988)
Novobiocin induces accumulation of a single strand of plasmid pGRB-1 in the archaebacterium Halobacterium GRB
Nucleic Acids Res, 16 (16), 7833-42
DOI 10.1093/nar/16.16.7833, PubMed 3419901
Sioud M, Possot O, Elie C, Sibold L, Forterre P (1988)
Coumarin and quinolone action in archaebacteria: evidence for the presence of a DNA gyrase-like enzyme
J Bacteriol, 170 (2), 946-53
DOI 10.1128/jb.170.2.946-953.1988, PubMed 2828337

Publications 1987

Sioud M, Baldacci G, Forterre P, de Recondo AM (1987)
Antitumor drugs inhibit the growth of halophilic archaebacteria
Eur J Biochem, 169 (2), 231-6
DOI 10.1111/j.1432-1033.1987.tb13602.x, PubMed 3121311
Sioud M, Forterre P, de Recondo AM (1987)
Effects of the antitumor drug VP16 (etoposide) on the archaebacterial Halobacterium GRB 1.7 kb plasmid in vivo
Nucleic Acids Res, 15 (20), 8217-34
DOI 10.1093/nar/15.20.8217, PubMed 3671082

Publications 1986

Bernard M, Sioud M, Percheron F, Foglietti MJ (1986)
beta-Mannosidase in human serum and urine. A comparative study
Int J Biochem, 18 (11), 1065-8
DOI 10.1016/0020-711x(86)90255-7, PubMed 3803698